These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 9582016
1. Activation of the Xmrk proto-oncogene of Xiphophorus by overexpression and mutational alterations. Dimitrijevic N, Winkler C, Wellbrock C, Gómez A, Duschl J, Altschmied J, Schartl M. Oncogene; 1998 Apr 02; 16(13):1681-90. PubMed ID: 9582016 [Abstract] [Full Text] [Related]
2. Melanoma loss-of-function mutants in Xiphophorus caused by Xmrk-oncogene deletion and gene disruption by a transposable element. Schartl M, Hornung U, Gutbrod H, Volff JN, Wittbrodt J. Genetics; 1999 Nov 02; 153(3):1385-94. PubMed ID: 10545466 [Abstract] [Full Text] [Related]
3. Transcriptional activation of the melanoma inducing Xmrk oncogene in Xiphophorus. Adam D, Mäueler W, Schartl M. Oncogene; 1991 Jan 02; 6(1):73-80. PubMed ID: 1846957 [Abstract] [Full Text] [Related]
4. The macromelanophore locus and the melanoma oncogene Xmrk are separate genetic entities in the genome of Xiphophorus. Weis S, Schartl M. Genetics; 1998 Aug 02; 149(4):1909-20. PubMed ID: 9691046 [Abstract] [Full Text] [Related]
5. Ligand-independent dimerization and activation of the oncogenic Xmrk receptor by two mutations in the extracellular domain. Gómez A, Wellbrock C, Gutbrod H, Dimitrijevic N, Schartl M. J Biol Chem; 2001 Feb 02; 276(5):3333-40. PubMed ID: 11038352 [Abstract] [Full Text] [Related]
6. Expression regulation triggers oncogenicity of xmrk alleles in the Xiphophorus melanoma system. Regneri J, Schartl M. Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jan 02; 155(1):71-80. PubMed ID: 21527356 [Abstract] [Full Text] [Related]
7. Evolutionary origin and molecular biology of the melanoma-inducing oncogene of Xiphophorus. Schartl A, Dimitrijevic N, Schartl M. Pigment Cell Res; 1994 Dec 02; 7(6):428-32. PubMed ID: 7761351 [Abstract] [Full Text] [Related]
8. Transcriptional control analyses of the Xiphophorus melanoma oncogene. Regneri J, Volff JN, Schartl M. Comp Biochem Physiol C Toxicol Pharmacol; 2015 Dec 02; 178():116-127. PubMed ID: 26348392 [Abstract] [Full Text] [Related]
9. The Xmrk oncogene promoter is derived from a novel amplified locus of unusual organization. Förnzler D, Altschmied J, Nanda I, Kolb R, Baudler M, Schmid M, Schartl M. Genome Res; 1996 Feb 02; 6(2):102-13. PubMed ID: 8919689 [Abstract] [Full Text] [Related]
14. Association between the melanoma-inducing receptor tyrosine kinase Xmrk and src family tyrosine kinases in Xiphophorus. Wellbrock C, Lammers R, Ullrich A, Schartl M. Oncogene; 1995 Jun 01; 10(11):2135-43. PubMed ID: 7540277 [Abstract] [Full Text] [Related]
17. Activation of phosphatidylinositol 3-kinase by a complex of p59fyn and the receptor tyrosine kinase Xmrk is involved in malignant transformation of pigment cells. Wellbrock C, Schartl M. Eur J Biochem; 2000 Jun 01; 267(12):3513-22. PubMed ID: 10848967 [Abstract] [Full Text] [Related]
18. Ligand-dependent tumor induction in medakafish embryos by a Xmrk receptor tyrosine kinase transgene. Winkler C, Wittbrodt J, Lammers R, Ullrich A, Schartl M. Oncogene; 1994 Jun 01; 9(6):1517-25. PubMed ID: 8183545 [Abstract] [Full Text] [Related]